Jerusalem, 20 October, 2026 (TPS-IL) — Decades of research have revealed much about Alzheimer’s disease, yet scientists still do not fully understand why it affects patients so differently. A new study proposes a computational framework that could help researchers connect findings from different fields and build a more comprehensive picture of the disease.
Researchers from Israel and the United States argue that genetic, biological and cognitive studies have often examined Alzheimer’s from separate perspectives. By linking specialized computer models, they hope to identify relationships that could help explain differences among patients and eventually inform more targeted clinical trials and treatments.
The study was led by Prof. Shahar Arzy of the Hebrew University of Jerusalem, with contributions from computer scientist Barak Raveh and Prof. Gad Marshall of Harvard Medical School. The researchers argue that no single model can adequately capture the complexity of Alzheimer’s disease.
Alzheimer’s disease, the leading cause of dementia worldwide, affects millions of people. It is associated with abnormal accumulation of amyloid and tau proteins in the brain. Inflammation, vascular damage, metabolic disturbances and other biological processes may also contribute to its development and progression. Patients can experience varying combinations of memory loss, language difficulties, disorientation and behavioral changes, as well as problems with visual processing or decision-making.
“This means that two people who receive the same diagnosis of Alzheimer’s disease may actually be experiencing very different combinations of biological and cognitive changes,” Arzy said.
“Instead of looking for a single explanation that fits every patient, we need to understand the individual profile of the disease,” he added.
To address this complexity, the researchers propose a method known as metamodeling. Rather than attempting to build one enormous model incorporating every available piece of information, the approach would connect specialized computer models examining brain scans, genetic information, molecular changes, cognitive symptoms and other factors. Mathematical links between the models could help researchers investigate how these different elements relate to one another.
If developed and validated, the framework could help researchers investigate why Alzheimer’s progresses differently among patients, identify patterns associated with different disease profiles and examine how biological processes interact.
It could also allow researchers to model hypothetical treatment scenarios and explore whether patients with similar biological characteristics might respond differently to particular interventions. Such findings could help inform future research and clinical trial design, although the framework’s usefulness would depend on further development and testing.
The study was published in the peer-reviewed journal, Brain.